INTRODUCTION AND OBJECTIVES:
To minimize morbidity of surgery or radiation, active surveillance (AS) is standard of care in lowrisk prostate cancer (PC). Predicting which men on AS will progress and require active treatment is challenging. This study describes a novel total cancer location (TCLo) density index and aims to determine its performance in predicting clinical progression (CP) and grade progression (GP).
METHODS: This was a retrospective study of patients on AS after confirmatory biopsy (CBx). We excluded patients with Gleason 7 or higher at CBx, less than 2 years follow-up and incomplete data. TCLo was the number of locations with positive cores at diagnosis (DBx) and CBx. TCLo density was TCLo / prostate volume (PV). CP was progression to any active treatment while GP occurred if Gleason 7 or higher was identified on repeat biopsy or surgical pathology. Independent predictors of time to CP or GP were estimated with Cox regression using age, PSA, number of positive CBx cores, TCLo and TCLo density as predictors. Kaplan-Meier analysis compared progression-free survival curves between high and low TCLo density groups. Test characteristics of TCLo were explored with receiver operating characteristic (ROC) curves.
RESULTS: Between 2012-2015, 421 patients had a CBx. We included 181 patients who met inclusion criteria. The mean age of patients at the start of AS was 62.6 years (SD[7.13) and the median PSA at diagnosis was 5. CONCLUSIONS: TCLo density has the potential to stratify patients into low or high risk for clinical and grade progression while on AS for low-risk PC. This should be validated with a larger prospective sample population.
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MP48-14 OUTCOMES OF RADICAL PROSTATECTOMY AFTER A PERIOD OF ACTIVE SURVEILLANCE
Ashwin Balakrishnan*, Janet Cowan, Peter Carroll, San Francisco, CA INTRODUCTION AND OBJECTIVES: As enrollment in active surveillance (AS) expands, it is increasingly important to assess potential risks of deferred treatment. We evaluate the risk of prostate specific antigen (PSA) recurrence in a large cohort of men undergoing radical prostatectomy (RP) after initial AS.
METHODS: The study included men undergoing RP after a period of AS with Gleason score (GS) 3þ3 or 3þ4 at diagnosis, clinical T2, and a low or intermediate risk Cancer of the Prostate Risk Assessment (CAPRA) score. Men were stratified by a composite variable of GS and volume of high grade cores at diagnosis. Primary outcome was recurrence after RP, defined as two consecutive PSAs !0.2 ng/ml or any secondary treatment within 12 months of RP.
RESULTS: Of 1,812 men enrolled in AS between 1994 and 2016, 431 (23.8%) underwent deferred RP. Median time to RP was 26 months . At diagnosis, 378 men (87.7%) had GS 3þ3 disease, 25 men (5.8%) had GS 3þ4 disease with one high grade core, and 28 men (6.5%) had GS 3þ4 with two or more high grade cores. Reasons for undergoing RP included biopsy upgrade to GS !3þ4 (289 men, 67.1%), greater than 33% positive cores on surveillance biopsy (55 men, 12.8%), and PSA doubling time less than 36 months (9 men, 2.1%). At surgery, 92 (21.3%) had GS !4þ3 tumors, 169 (39.2%) had pT3/4 disease, and 10 (2.3%) had positive lymph nodes. Recurrence free survival was 88% at 2 years after RP. Among men with PSA recurrence, median time to recurrence was 15 months . Kaplan-Meier analysis showed a significant difference in the risk of recurrence between patients with GS 3þ3, 3þ4 with one high grade core, and 3þ4 with two or more high grade cores at diagnosis (logrank p[0.02). On multivariable analysis GS 3þ4 with two or more high grade cores at diagnosis was associated with risk of recurrence when compared to GS 3þ3 disease (HR 2.65, 95%CI 1.23-5.69), while GS 3þ4 with one high grade core did not differ from GS 3þ3, adjusted for age and PSA density (see table) .
CONCLUSIONS: The majority of patients undergoing deferred RP after a period of AS did not have any adverse features at the time of surgery. Our results support the careful use of AS in men with GS 3þ4 and one high grade core at diagnosis. Men with GS 3þ4 and two or more high grade cores at diagnosis had a significantly greater risk of recurrence, and likely benefit from immediate treatment.
